Qi Yi Luo
Director/Board Member at MICROPORT SCIENTIFIC CORPORATION
Net worth: 5 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zhao Hua Chang | M | 61 | 26 years | |
| Jeffrey Lindstrom | M | 58 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 2 years |
| Jonathan W. Chen | M | 49 |
MicroPort Cardiac Rhythm Management International Ltd.
 MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 12 years |
| Jonathan Chou | M | 60 | 14 years | |
| Guo Jia Wu | M | 51 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 4 years |
| Luy Ing Yan | F | 43 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 4 years |
| Guo Ming Chen | M | 39 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 4 years |
| Michel Darnaud | M | 74 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | - |
| Jun Jie Zhang | M | 47 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 7 years |
| Betty Tsai | F | 51 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | - |
| Jiandong Ding | M | 59 | 3 years | |
| Xian Gmei Li | F | - |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 10 years |
| Zhi Xiang Sun | F | 56 | 4 years | |
| Xia Wu | F | 43 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 7 years |
| Benoît Clinchamps | M | 58 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 4 years |
| Hiroshi Shirafuji | M | 80 | 16 years | |
| Chun Yang Shao | M | 60 | 8 years | |
| Bo Peng | M | 56 | 23 years | |
| Guo En Liu | M | 67 | 14 years | |
| Hong Bin Sun | M | 48 | 14 years | |
| Chien Cheng Lin | M | 53 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | - |
| Glendy Wang | F | 67 | 7 years | |
| Bruce Wang | M | - | 9 years | |
| Xiao Ming Zhu | M | 56 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 10 years |
| Vincent Leveaux | M | 49 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 16 years |
| Norihiro Ashida | M | 70 | 18 years | |
| Xiao Huang | M | 39 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 4 years |
| Paul Vodden | M | 58 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | - |
| Liang Zhao | M | 45 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | 2 years |
| Wing Yan Yuen | F | 53 | 4 years | |
| Xin Sun | M | 43 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 4 years |
| Philippe Wanstok | M | - |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 7 years |
| Yin Shan Hui | F | 56 |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | 1 years |
| Lok Yee Chan | F | 35 | 4 years | |
| Wei Qin Sun | F | 44 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yan Zhang | F | 54 | - | |
| Mike Nazwaski | M | - |
Queen's University
| 5 years |
| Adam Shah | M | - |
Queen's University
| 7 years |
| Kong Rong Pan | M | 65 | - | |
| Steven Wood | M | - |
Queen's University
| 6 years |
| David S. Wai | M | 52 |
Queen's University
| 5 years |
| Ze Zhao Hua | M | 86 | - | |
| Li Wang | M | 55 | 10 years | |
| Hua Liang Jiang | M | 59 | 1 years | |
| Michael T. R. List | M | 53 |
Queen's University
| 4 years |
| Brad Elberg | M | - |
Queen's University
| 4 years |
| Xiu Ru Xie | M | 62 |
Queen's University
| 3 years |
| Joshua P. Kleban | M | 53 |
Queen's University
| 4 years |
| Heather Allen | F | 56 |
Queen's University
| 4 years |
| Ann Driscoll | F | - |
Queen's University
| 4 years |
| Bruce Ing | M | - |
Queen's University
| 4 years |
| Erin Crowe | F | 53 |
Queen's University
| 4 years |
| Stacy Kimmett | F | - |
Queen's University
| 4 years |
| Chand Sooran | M | - |
Queen's University
| 2 years |
| Douglas Slater Grieve | M | - |
Queen's University
| 2 years |
| Mark Andrew Irwin | M | - |
Queen's University
| 3 years |
| Shuang Xie | M | 55 |
Queen's University
| 4 years |
| W. Guest | M | 62 |
Queen's University
| 3 years |
| William Bennett | M | 74 |
Queen's University
| 3 years |
| Eric Brouwer | M | - |
Queen's University
| 4 years |
| Gillian Whitebread | F | - |
Queen's University
| 4 years |
| Helen Victoria Hayes | F | - |
Queen's University
| 3 years |
| Steve Fiorelli | M | - |
Queen's University
| 4 years |
| John Windover | M | - |
Queen's University
| 4 years |
| Mike Dilworth | M | - |
Queen's University
| 4 years |
| Marc McQuillen | M | - |
Queen's University
| 4 years |
| Patrick Keefe | M | - |
Queen's University
| 4 years |
| Scott Ferguson | M | - |
Queen's University
| 2 years |
| Jacqueline Lucille Allard | F | - |
Queen's University
| 4 years |
| Robert E. Sheldrick | M | - |
Queen's University
| 4 years |
| Joe Timlin | M | - |
Queen's University
| 4 years |
| Dominique Barker | F | 52 |
Queen's University
| 5 years |
| Carolyn Susan Dennis | F | - |
Queen's University
| 4 years |
| Mark Selby | M | 58 |
Queen's University
| 4 years |
| Paul Olmsted | M | 63 |
Queen's University
| 2 years |
| Christopher Berlet | M | - |
Queen's University
| 4 years |
| Marie E. Beyette | F | - |
Queen's University
| 3 years |
| Dan Cohn-Sfetcu | M | 50 |
Queen's University
| 4 years |
| James A. Mott | M | - |
Queen's University
| 3 years |
| Alexander Clarke | M | - |
Queen's University
| 2 years |
| Edward Buiel | M | 52 |
Queen's University
| 4 years |
| Nils Voermann | M | - |
Queen's University
| 4 years |
| Joseph Hamilton | M | - |
Queen's University
| 1 years |
| Allan G. Burton | M | - |
Queen's University
| 3 years |
| Jzaneen Lalani | F | 51 |
Queen's University
| 4 years |
| T. Kirk Boyd | M | - |
Queen's University
| 4 years |
| Robert Cummings | M | 59 |
Queen's University
| 2 years |
| Gordon S. Bakarich | M | - |
Queen's University
| 4 years |
| Zohrab Mawani | M | - |
Queen's University
| 4 years |
| Leslie F. Kende | M | - |
Queen's University
| 4 years |
| Veronica Farmer | F | - |
Queen's University
| 4 years |
| Tim Sun | M | 62 |
Queen's University
| 3 years |
| Shannon C. Shaw | F | 53 |
Queen's University
| 4 years |
| Patrick M. Boucher | M | - |
Queen's University
| 3 years |
| James G. McVicar | M | 58 |
Queen's University
| 4 years |
| Duncan Middlemiss | M | 62 |
Queen's University
| 4 years |
| Hing Keung Mak | M | 61 |
Queen's University
| 4 years |
| A. Stewart Campbell | M | - |
Queen's University
| 3 years |
| Brent Roland | M | - |
Queen's University
| 4 years |
| Jason Macfarlane | M | - |
Queen's University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 60 | 60.00% |
| Cayman Islands | 28 | 28.00% |
| China | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Qi Yi Luo
- Personal Network
